Page last updated: 2024-11-02

pd 98059 and Diabetes Mellitus, Type 2

pd 98059 has been researched along with Diabetes Mellitus, Type 2 in 10 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cha, JJ1
Hyun, YY1
Jee, YH1
Lee, MJ1
Han, KH1
Kang, YS1
Han, SY1
Cha, DR1
Matsumoto, T2
Ishida, K1
Nakayama, N1
Kobayashi, T2
Kamata, K2
Su, XL1
Wang, Y1
Zhang, W1
Zhao, LM1
Li, GR1
Deng, XL1
Buonomo, R1
Giacco, F1
Vasaturo, A1
Caserta, S1
Guido, S1
Pagliara, V1
Garbi, C1
Mansueto, G1
Cassese, A1
Perruolo, G1
Oriente, F1
Miele, C1
Beguinot, F1
Formisano, P1
Taguchi, K1
Tokuda, H1
Kato, K1
Kasahara, S1
Matsushima-Nishiwaki, R1
Mizuno, T1
Sakakibara, S1
Kozawa, O1
Ramos-Álvarez, I1
Martín-Duce, A1
Moreno-Villegas, Z1
Sanz, R1
Aparicio, C1
Portal-Núñez, S1
Mantey, SA1
Jensen, RT1
González, N1
Li, L1
Sawamura, T1
Renier, G1
Foutz, RM1
Grimm, PR1
Sansom, SC1
Collins, AR1
Meehan, WP1
Kintscher, U1
Jackson, S1
Wakino, S1
Noh, G1
Palinski, W1
Hsueh, WA1
Law, RE1

Other Studies

10 other studies available for pd 98059 and Diabetes Mellitus, Type 2

ArticleYear
Plasma concentration of soluble intercellular adhesion molecule-1 (sICAM-1) is elevated in type 2 diabetic patients, and sICAM-1 synthesis is associated with leptin-induced activation of the mitogen-activated protein kinase (MAPK) pathway.
    Inflammation, 2013, Volume: 36, Issue:4

    Topics: Albuminuria; Blood Glucose; Body Mass Index; Cells, Cultured; Creatinine; Diabetes Mellitus, Type 2;

2013
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Butadienes; Diabetes Mellitus, Type 2; Diabetic Angio

2009
Insulin-mediated upregulation of K(Ca)3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle.
    Journal of molecular and cellular cardiology, 2011, Volume: 51, Issue:1

    Topics: Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cell Movement; Cell Proliferation; Cel

2011
PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms.
    Journal of cellular physiology, 2012, Volume: 227, Issue:5

    Topics: Animals; Apoptosis Regulatory Proteins; Cell Adhesion; Cell Movement; Cells, Cultured; Diabetes Mell

2012
Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
    Pharmacological research, 2012, Volume: 66, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Diabetes Mellitus, Type 2;

2012
Significant correlation between the acceleration of platelet aggregation and phosphorylation of HSP27 at Ser-78 in diabetic patients.
    International journal of molecular medicine, 2012, Volume: 30, Issue:6

    Topics: Adenosine Diphosphate; Aged; Blood Platelets; Case-Control Studies; CD40 Ligand; Diabetes Mellitus,

2012
Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes.
    Molecular and cellular endocrinology, 2013, Mar-10, Volume: 367, Issue:1-2

    Topics: Adult; Aged; Androstadienes; Animals; Biological Transport; Cells, Cultured; Diabetes Mellitus, Type

2013
Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
    Circulation research, 2004, Apr-16, Volume: 94, Issue:7

    Topics: Acetylcysteine; Adult; Aged; Anti-Infective Agents; Antioxidants; Arteriosclerosis; Cells, Cultured;

2004
Insulin increases the activity of mesangial BK channels through MAPK signaling.
    American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:6

    Topics: Animals; Butadienes; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fat

2008
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:3

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Arteriosclerosis; Blood Glu

2001